<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36652923</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1940-1574</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Angiology</Title><ISOAbbreviation>Angiology</ISOAbbreviation></Journal><ArticleTitle>Vascular "Long COVID": A New Vessel Disease?</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>14</EndPage><MedlinePgn>8-14</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">00033197231153204</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/00033197231153204</ELocationID><Abstract><AbstractText>Vascular sequelae following (SARS-CoV-2 coronavirus disease) (COVID)-19 infection are considered as "Long Covid (LC)" disease, when occurring 12&#xa0;weeks after the original infection. The paucity of specific data can be obviated by translating pathophysiological elements from the original Severe Acute Respiratory Syndrome-Corona Virus (SARS-CoV-2) infection (In a microcirculatory system, a first "endotheliitis," is often followed by production of "Neutrophil Extracellular Trap," and can evolve into a more complex leukocytoklastic-like and hyperimmune vasculitis. In medium/large-sized vessels, this corresponds to endothelial dysfunction, leading to an accelerated progression of pre-existing atherosclerotic plaques through an increased deposition of platelets, circulating inflammatory cells and proteins. Associated dysregulated immune and pro-coagulant conditions can directly cause thrombo-embolic arterial or venous complications. In order to implement appropriate treatment, physicians need to consider vascular pathologies observed after SARS-Cov-2 infections as possible "LC" disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zanini</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selleri</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto Nazionale per le Ricerche Cardiovascolari, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roncati</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pathology Unit, University of Modena and Reggio Emilia. Polyclinic Hospital, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and. Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasi</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical and Dental Sciences University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farinetti</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and. Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manenti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0523-9515</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and. Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinti</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattioli</LastName><ForeName>Anna Vittoria</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-1487-9530</Identifier><AffiliationInfo><Affiliation>Istituto Nazionale per le Ricerche Cardiovascolari, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and. Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Angiology</MedlineTA><NlmUniqueID>0203706</NlmUniqueID><ISSNLinking>0003-3197</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Angiology. 2024 Jan;75(1):98. doi: 10.1177/00033197231167051</RefSource><PMID Version="1">36964670</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">arterial thrombosis</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">vascular complications</Keyword><Keyword MajorTopicYN="N">vasculitis</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36652923</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370:m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli AV, Coppi F, Nasi M, Pinti M, Gallina S. Long COVID: a new challenge for prevention of obesity in women. Am J Lifestyle Med. 2023;17:164-168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9830233</ArticleId><ArticleId IdType="pubmed">36636391</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, et al.Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20:1115-1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinetti A, Manenti A, Manco G, Roncati L, Coppi F, Mattioli AV. From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology. J Vasc Surg. 2022;76:1427-1428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9581817</ArticleId><ArticleId IdType="pubmed">36273847</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al.Attributes and predictors of long COVID. Nat Med. 2021;27:626-631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al.6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220-232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee. Gluckman TJ, Bhave NM, et al.2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play. J Am Coll Cardiol. 2022;79:1717-1756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer M, Szepanowski F, Tovar M, et al.Post-COVID-19 syndrome is rarely associated with damage of the nervous system: findings from a prospective observational cohort study in 171 patients. Neurol Therap. 2022;11:1637-1657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417089</ArticleId><ArticleId IdType="pubmed">36028604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E, Buonsenso D, Carfi A, et al.Long COVID: an estrogen-associated autoimmune disease? Cell Death Discovery. 2021;7:77-79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, for Gemelli Against COVID-19 Post-Acute Care Study Group . Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603-605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell&#x2019;Isola A, et al.Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13:7363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjonbalaj N, Uka S, Olluri E, et al.Renal artery thrombosis as a long-term complication of COVID-19. Radiol Case Rep. 2023;18:260-265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9631237</ArticleId><ArticleId IdType="pubmed">36345461</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabioni L, De Lorenzo A, Castro-Faria-Neto HC, Estato V, Tibirica E. Long-term assessment of systemic microcirculatory function and plasma cytokines after coronavirus disease 2019 (COVID-19). Braz J Infect Dis. 2022;27:102719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9670297</ArticleId><ArticleId IdType="pubmed">36423696</ArticleId></ArticleIdList></Reference><Reference><Citation>Landmesser U, Lehmann I, Eils R. Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19. Eur Heart J. 2021;42:1720-1721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083590</ArticleId><ArticleId IdType="pubmed">33822037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D, Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res. 2020;68:310-313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499017</ArticleId><ArticleId IdType="pubmed">32946016</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L, Manenti A, Manco G, Farinetti A, Mattioli A. The COVID-19 arterial thromboembolic complications: from inflammation to immunothrombosis through antiphospholipid autoantibodies. Ann Vasc Surg. 2021;72:216-217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837102</ArticleId><ArticleId IdType="pubmed">33387619</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature. 2021;590:29-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D, Campisi J, Verdin E, et al.Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822-1832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20:389-391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al.Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Manenti A, Farinetti A, Manco G, Mattioli A. Vasculitis and aortitis: COVID-19 challenging complications. J Vasc Surg. 2021;73:347-348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462784</ArticleId><ArticleId IdType="pubmed">32889075</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. 2021;31:1-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukalov A, Girault V, Grass V, et al.Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021;594:246-252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33845483</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L, De Biasi S, Paolini A, et al.Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020;12:e13001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645870</ArticleId><ArticleId IdType="pubmed">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G, De Gaetano A, Selleri V, et al.Mitochondrial DNA and exercise: implications for health and injuries in sports. Cells. 2021;10:2575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8533813</ArticleId><ArticleId IdType="pubmed">34685555</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gaetano A, Solodka K, Zanini G, et al.Molecular mechanisms of mtDNA-mediated inflammation. Cells. 2021;10:2898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616383</ArticleId><ArticleId IdType="pubmed">34831121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Tartaro D, Neroni A, Paolini A, et al.Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia. Communications Biol. 2022;5:590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203559</ArticleId><ArticleId IdType="pubmed">35710943</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio J, Gulen MF, Saidoune F, et al.The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603:145-151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev. 2021;47:100761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543932</ArticleId><ArticleId IdType="pubmed">33067035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni MG, Piantoni S, Masneri S, et al.Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021;46:100745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli AV, Coppi F, Manenti A, Farinetti A. Subclinical vascular damage: current insights and future potential. Vasc Health Risk Manag. 2021;17:729-738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633547</ArticleId><ArticleId IdType="pubmed">34866906</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher R, Breakey N, L&#xe4;mmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156948</ArticleId><ArticleId IdType="pubmed">32305740</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al.Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Ren Z, Xu W, Jiang Z. Necroptosis in atherosclerosis. Clin Chim Acta. 2022;534:22-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">35809652</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Vitale I, Aaronson S, et al.Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25:486-541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5864239</ArticleId><ArticleId IdType="pubmed">29362479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Han Y, Zhang R, et al.Regulated necrosis in COVID-19: a double-edged sword. Front Immunol. 2022;13:917141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452688</ArticleId><ArticleId IdType="pubmed">36090995</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, He XY, Denorme F, et al.Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169-1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco A, Coronado MJ, Hern&#xe1;ndez-Terciado F, et al.Assessment of neutrophil extracellular traps in coronary thrombus of a case series of patients with COVID-19 and myocardial infarction. JAMA Cardiol. 2020;6:1-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7772744</ArticleId><ArticleId IdType="pubmed">33372956</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L, Ligabue G, Fabbiani L, et al.Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020;217:108487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256503</ArticleId><ArticleId IdType="pubmed">32479986</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, et al.Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21:319-329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunin P, Bouslama R, Machlus KR, et al.Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. Elife. 2019;8:e44031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494422</ArticleId><ArticleId IdType="pubmed">31042146</ArticleId></ArticleIdList></Reference><Reference><Citation>Petzold T, Zhang Z, Ballesteros I, et al.Neutrophil &#x201c;plucking&#x201d; on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022;55(12):2285-2299.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9767676</ArticleId><ArticleId IdType="pubmed">36272416</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al.Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (New York, N.Y.). 2020;370(6515):eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, et al.Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res. 2020;116:2177-2184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19. Circulation. 2020;142:68-78.</Citation><ArticleIdList><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagris M, Theofilis P, Antonopoulos AS, et al.Inflammatory mechanisms in COVID-19 and atherosclerosis: current pharmaceutical perspectives. Int J Mol Sci. 2021;22:6607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8234423</ArticleId><ArticleId IdType="pubmed">34205487</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba L, Sanagala SS, Gupta SK, et al.Multimodality carotid plaque tissue characterization and classification in the artificial intelligence paradigm: a narrative review for stroke application. Ann Transl Med. 2021;9:1206-1206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8350643</ArticleId><ArticleId IdType="pubmed">34430647</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L, Manenti A, Manco G, Farinetti A, Mattioli AV. COVID-19 thromboembolic complications: deepening immunoinflammatory features. J Vasc Surg. 2021;74:1048-1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8376811</ArticleId><ArticleId IdType="pubmed">34425948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article - Acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog Cardiovasc Dis. 2020;63:682-689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopf J, Brostjan C, Eilenberg W, Neumayer C. Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease. Int J Mol Sci. 2021;22:559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7828090</ArticleId><ArticleId IdType="pubmed">33429925</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, et al.Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasal DA, De Lorenzo A, Tibiri&#xe7;&#xe1; E. COVID-19 and microvascular disease: pathophysiology of SARS-CoV-2 infection with focus on the renin-angiotensin system. Heart Lung Circ. 2020;29:1596-1602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467122</ArticleId><ArticleId IdType="pubmed">32972810</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoli L, Gaudio A, Mikhailidis DP, et al.Vascular dysfunction of COVID-19 is partially reverted in the long-term. Circ Res. 2022;130:1276-1285.</Citation><ArticleIdList><ArticleId IdType="pubmed">35345906</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>